Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Alpha Galactosidase A Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Alpha Galactosidase A Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Agalsidase Alfa
      • 1.3.3 AVRRD-01
      • 1.3.4 Migalastat Hydrochloride
      • 1.3.5 MOSS-AGAL
      • 1.3.6 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Alpha Galactosidase A Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Clinic
      • 1.4.4 Home Care
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Alpha Galactosidase A Market Size
      • 2.1.1 Global Alpha Galactosidase A Revenue 2014-2025
      • 2.1.2 Global Alpha Galactosidase A Sales 2014-2025
    • 2.2 Alpha Galactosidase A Growth Rate by Regions
      • 2.2.1 Global Alpha Galactosidase A Sales by Regions 2014-2019
      • 2.2.2 Global Alpha Galactosidase A Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Alpha Galactosidase A Sales by Manufacturers
      • 3.1.1 Alpha Galactosidase A Sales by Manufacturers 2014-2019
      • 3.1.2 Alpha Galactosidase A Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Alpha Galactosidase A Revenue by Manufacturers (2014-2019)
      • 3.2.2 Alpha Galactosidase A Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Alpha Galactosidase A Market Concentration Ratio (CR5 and HHI)
    • 3.3 Alpha Galactosidase A Price by Manufacturers
    • 3.4 Key Manufacturers Alpha Galactosidase A Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Alpha Galactosidase A Market
    • 3.6 Key Manufacturers Alpha Galactosidase A Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Agalsidase Alfa Sales and Revenue (2014-2019)
      • 4.1.2 AVRRD-01 Sales and Revenue (2014-2019)
      • 4.1.3 Migalastat Hydrochloride Sales and Revenue (2014-2019)
      • 4.1.4 MOSS-AGAL Sales and Revenue (2014-2019)
      • 4.1.5 Others Sales and Revenue (2014-2019)
    • 4.2 Global Alpha Galactosidase A Sales Market Share by Type
    • 4.3 Global Alpha Galactosidase A Revenue Market Share by Type
    • 4.4 Alpha Galactosidase A Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Alpha Galactosidase A Sales by Application

    6 United States

    • 6.1 United States Alpha Galactosidase A Breakdown Data by Company
    • 6.2 United States Alpha Galactosidase A Breakdown Data by Type
    • 6.3 United States Alpha Galactosidase A Breakdown Data by Application

    7 European Union

    • 7.1 European Union Alpha Galactosidase A Breakdown Data by Company
    • 7.2 European Union Alpha Galactosidase A Breakdown Data by Type
    • 7.3 European Union Alpha Galactosidase A Breakdown Data by Application

    8 China

    • 8.1 China Alpha Galactosidase A Breakdown Data by Company
    • 8.2 China Alpha Galactosidase A Breakdown Data by Type
    • 8.3 China Alpha Galactosidase A Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Alpha Galactosidase A Breakdown Data by Company
    • 9.2 Rest of World Alpha Galactosidase A Breakdown Data by Type
    • 9.3 Rest of World Alpha Galactosidase A Breakdown Data by Application
    • 9.4 Rest of World Alpha Galactosidase A Breakdown Data by Countries
      • 9.4.1 Rest of World Alpha Galactosidase A Sales by Countries
      • 9.4.2 Rest of World Alpha Galactosidase A Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Amicus Therapeutics, Inc.
      • 10.1.1 Amicus Therapeutics, Inc. Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Alpha Galactosidase A
      • 10.1.4 Alpha Galactosidase A Product Introduction
      • 10.1.5 Amicus Therapeutics, Inc. Recent Development
    • 10.2 Greenovation Biotech GmbH
      • 10.2.1 Greenovation Biotech GmbH Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Alpha Galactosidase A
      • 10.2.4 Alpha Galactosidase A Product Introduction
      • 10.2.5 Greenovation Biotech GmbH Recent Development
    • 10.3 iBio, Inc.
      • 10.3.1 iBio, Inc. Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Alpha Galactosidase A
      • 10.3.4 Alpha Galactosidase A Product Introduction
      • 10.3.5 iBio, Inc. Recent Development
    • 10.4 ISU ABXIS Co.,Ltd.
      • 10.4.1 ISU ABXIS Co.,Ltd. Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Alpha Galactosidase A
      • 10.4.4 Alpha Galactosidase A Product Introduction
      • 10.4.5 ISU ABXIS Co.,Ltd. Recent Development
    • 10.5 JCR Pharmaceuticals Co., Ltd.
      • 10.5.1 JCR Pharmaceuticals Co., Ltd. Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Alpha Galactosidase A
      • 10.5.4 Alpha Galactosidase A Product Introduction
      • 10.5.5 JCR Pharmaceuticals Co., Ltd. Recent Development
    • 10.6 Pharming Group N.V.
      • 10.6.1 Pharming Group N.V. Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Alpha Galactosidase A
      • 10.6.4 Alpha Galactosidase A Product Introduction
      • 10.6.5 Pharming Group N.V. Recent Development
    • 10.7 Protalix BioTherapeutics, Inc.
      • 10.7.1 Protalix BioTherapeutics, Inc. Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Alpha Galactosidase A
      • 10.7.4 Alpha Galactosidase A Product Introduction
      • 10.7.5 Protalix BioTherapeutics, Inc. Recent Development
    • 10.8 Shire Plc
      • 10.8.1 Shire Plc Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Alpha Galactosidase A
      • 10.8.4 Alpha Galactosidase A Product Introduction
      • 10.8.5 Shire Plc Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Alpha Galactosidase A Sales Channels
      • 11.2.2 Alpha Galactosidase A Distributors
    • 11.3 Alpha Galactosidase A Customers

    12 Market Forecast

    • 12.1 Global Alpha Galactosidase A Sales and Revenue Forecast 2019-2025
    • 12.2 Global Alpha Galactosidase A Sales Forecast by Type
    • 12.3 Global Alpha Galactosidase A Sales Forecast by Application
    • 12.4 Alpha Galactosidase A Forecast by Regions
      • 12.4.1 Global Alpha Galactosidase A Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Alpha Galactosidase A Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Alpha Galactosidase A is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Alpha Galactosidase A.

      This report studies the global market size of Alpha Galactosidase A, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Alpha Galactosidase A sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Amicus Therapeutics, Inc.
      Greenovation Biotech GmbH
      iBio, Inc.
      ISU ABXIS Co.,Ltd.
      JCR Pharmaceuticals Co., Ltd.
      Pharming Group N.V.
      Protalix BioTherapeutics, Inc.
      Shire Plc

      Market Segment by Product Type
      Agalsidase Alfa
      AVRRD-01
      Migalastat Hydrochloride
      MOSS-AGAL
      Others

      Market Segment by Application
      Hospital
      Clinic
      Home Care

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Alpha Galactosidase A status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Alpha Galactosidase A manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Alpha Galactosidase A are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now